Direkt zum Inhalt

Nuhn, P. ; May, M. ; Fritsche, H.-M. ; Buchner, A. ; Brookman-May, S. ; Bolenz, C. ; Moritz, R. ; Herrmann, E. ; Burger, M. ; Höfner, T. ; Ellinger, J. ; Tilki, D. ; Roigas, J. ; Zacharias, M. ; Trojan, L. ; Wülfing, C. ; May, F. ; Melchior, S. ; Haferkamp, A. ; Gilfrich, C. ; Hohenfellner, M. ; Wieland, W.F. ; Müller, S.C. ; Stief, C.G. ; Bastian, P.J.

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

Article

Nuhn, P., May, M., Fritsche, H.-M., Buchner, A. , Brookman-May, S., Bolenz, C., Moritz, R., Herrmann, E., Burger, M., Höfner, T., Ellinger, J. , Tilki, D., Roigas, J., Zacharias, M., Trojan, L., Wülfing, C., May, F., Melchior, S., Haferkamp, A., Gilfrich, C., Hohenfellner, M., Wieland, W.F., Müller, S.C., Stief, C.G. and Bastian, P.J. (2012) External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. European Journal of Surgical Oncology (EJSO) 38 (7), pp. 637-642.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleEuropean Journal of Surgical Oncology (EJSO)
PublisherELSEVIER SCI LTD
Place of PublicationOXFORD
Volume38
Number of Issue or Book Chapter7
Page Rangepp. 637-642
Date2012
Date of publication19 Dec 2024 09:39
InstitutionsMedicine > Lehrstuhl für Urologie
Identification Number
ValueType
10.1016/j.ejso.2012.02.187DOI
Keywords18 RANDOMIZED-TRIALS; CLINICAL-TRIALS; COLON-CANCER; Bladder cancer; Disease-free survival; Primary endpoint; Prognosis; Radical cystectomy; Urothelial carcinoma
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID63605

Export bibliographical data

Owner only: item control page

nach oben